
    
      A single-centre, open-label, randomized, single-dose, 6-way crossover study to investigate
      the pharmacokinetics, safety and tolerability of 6 different formulations of SB-649868 30 mg
      (Part A) and the effect of food on the selected formulation of SB-649868 pharmacokinetic
      (Part B) in healthy male volunteers
    
  